Evidence map›Paper›PMID 37085813›Full record

SynthesisBMC endocrine disorders2023

Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials.

Sepideh Soltani, Marziyeh Ashoori, Fereshteh Dehghani, Fatemeh Meshkini, Zachary Stephen Clayton, Shima Abdollahi

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC endocrine disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Sepideh SoltaniYazd Cardiovascular Research Center, Noncommunicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Marziyeh AshooriSchool of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fereshteh DehghaniDepartment of nutritional Sciences, Texas Tech University, Lubbock, TX, USA.
Fatemeh MeshkiniDepartment of Biochemistry, School of medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Zachary Stephen ClaytonDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA.
Shima AbdollahiDepartment of Nutrition, School of Public Health, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Shahid Sadoughi University of Medical Sciences and Health Services · IRNorth Khorasan University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRTexas Tech University · USUniversity of Colorado Boulder · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of the present study was to assess the effect of probiotic/synbiotic supplementation on anthropometric measures in adults with diabetes, independent of body weight.

methodsPubMed, Scopus, Web of Sciences and the Cochrane Library were searched for randomized controlled trials (RCTs) up until December 14, 2022. The effect sizes were pooled using an inverse-variance random-effects model. The methodological quality of studies as well as the quality of evidence was assessed using standard tools.

resultsThirty-two RCTs met the established inclusion criteria. Overall, compared with the respective control groups, probiotic/synbiotic supplementation resulted in a significant reduction in body weight (weighted mean difference [WMD]: -0.50 kg; 95% CI: -0.83, -0.17; I

conclusionsOur analysis revealed that probiotic/synbiotic supplementation may assist with weight management in patients with diabetes, especially when consumed at higher doses, in younger adults, and in participants with obesity. However, more studies are needed to elucidate the anti-obesity effects of specific strains of probiotics/synbiotics.

Indexed as

Diabetes MellitusProbioticsSynbioticsAdultBody WeightDietary SupplementsHumansObesityRandomized Controlled Trials as TopicDiabetesMeta-analysisObesityProbioticsSynbioticsSystematic-review

Identifiers

PMID37085813
PMCPMC10120130
OpenAlexW4366742726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.